Porter Jeffrey H 4
4 · cbdMD, Inc. · Filed Apr 16, 2026
Research Summary
AI-generated summary of this filing
cbdMD (YCBD) Director Jeffrey H. Porter Receives RSU Award
What Happened
Jeffrey H. Porter, a director of cbdMD, Inc. (YCBD), was granted 1,572 restricted stock units (RSUs) on April 14, 2026. The award was reported on a Form 4 filed April 16, 2026. The RSUs were issued at $0.00 (no cash paid) as a compensatory grant rather than an open‑market purchase or sale.
Key Details
- Transaction type: Award/Grant (Form 4 code A) — 1,572 RSUs granted at $0.00.
- Grant exemption: Issued under Rule 16b-3 and approved in advance by the Compensation, Corporate Governance and Nominating Committee.
- Vesting: Quartely vesting on 6/30/2026, 9/30/2026, 12/31/2026 and 3/31/2027.
- Plan: Issued under the Issuer’s 2021 or 2025 Equity Compensation Plan as board compensation (per footnote F1).
- Shares beneficially owned after the transaction: Not specified in the information provided.
- Footnote F2: Indicates the reporting person holds voting and dispositive control over shares held by an entity (separate from the RSU grant).
- Filing timeliness: Form 4 filed two days after the transaction date (appears timely).
Context
RSUs are a form of compensation that convert into shares if and when they vest; they are not an immediate cash purchase and do not necessarily indicate direct buying or selling intent. Grants to directors are common as part of board compensation and, while they increase potential future share supply, they are primarily a remuneration mechanism rather than a direct market signal.
Insider Transaction Report
- Award
Common Stock
[F1]2026-04-14+1,572→ 3,144 total
- 465,955(indirect: By Porter Partners L.P.)
Common Stock
[F2] - 61,750(indirect: By Ben Joseph Partners)
Common Stock
[F2] - 41,275(indirect: By IRA)
Common Stock
[F2] - 4,550(indirect: By Trust)
Common Stock
[F2]
Footnotes (2)
- [F1]Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027. The restricted stock units were issued under the 2021 or 2025 Equity Compensation Plan as compensation to the Reporting Person for services on the Issuer's Board of Directors.
- [F2]Represents shares of common stock held by an entity for which the Reporting Person holds voting and dispositive control.